“When people gather indoors with family and friends during the holidays, we cannot back down on all the preventive public health measures that we have been taking during the pandemic. As the Delta and Omicron variants continue to spread, vaccination remains the best protection against Covid-19 “, added the entity in full increase of infections.
On November 19, the FDA authorized the application of a single booster dose of the Pfizer / BioNTech vaccine to those over 18 years of age who have completed primary immunization with any drug approved by the agency.
Meanwhile, young people between 16 and 17 years old will be able to administer third doses of Pfizer / BioNTech, which is the only one approved.
“The Pfizer-BioNTech vaccine has been available to people 16 years of age and older for almost a year, and its benefits have been shown to clearly outweigh the potential risks,” said Peter Marks, director of the Center for Evaluation and Research of FDA Biological Products.
The news of the approval of the use of the drugs in young people of 16 and 17 years comes a day after the pharmaceutical companies of Pfizer and BioNTech reported that two doses of their vaccine were significantly less effective in neutralizing the omicron variant in the first tests. but that a three-dose regimen was more effective.
Last month, the United States authorized the application of the inoculation for children up to five years old, with special injections from Pfizer in low doses.
Until today, around 5 million children between the ages of 5 and 11 had received a first dose of the drug.
Source From: Ambito
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.
